Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancer

Abstract : Background: colorectal cancer (CRC) remains a major public concern. While conventional chemotherapeutic regimens have proved useful against advanced/metastatic diseases, progresses are to be made to effectively cure the large portion of patients not benefiting from these treatments. One direction to improve response rates is to develop chemosensitivity and resistance assays (CSRAs) efficiently assisting clinicians in treatment selection process, an already long preoccupation of oncologists and researchers. Several methods have been described to this day, none achieving yet sufficient reliability for recommended use in the clinical routine. Methods: We led a pilot study on 19 metastatic CRC patients evaluating capacity of the Oncogramme, a standardized process using tumor ex vivo models, to provide chemosensitivity profiles and predict clinical outcome of patients receiving standard CRC chemotherapeutics. Oncogramme responses were categorized according to the method of percentiles to assess sensitivity, specificity and concordance. Results: We report from a primary analysis a success rate of 97.4 %, a very good sensitivity (84.6 %), a below-average specificity (33.3 %), along with a global agreement of 63.6 % and a concordance between Oncogramme results and patients’ responses (Kappa coefficient) of 0.193. A supplementary analysis, focusing on CRC patients with no treatment switch over a longer time course, demonstrated improvement in specificity and concordance. Conclusions: Results establish feasibility and usefulness of the Oncogramme, prelude to a larger-scale trial. Advantages and drawbacks of the procedure are discussed, as well as the place of CSRAs within the future arsenal of methods available to clinicians to individualize treatments and improve patient prognosis.
Type de document :
Article dans une revue
Journal of Translational Medicine, BioMed Central, 2016, 14 (1), pp.10. 〈10.1186/s12967-016-0765-4〉
Liste complète des métadonnées

Littérature citée [53 références]  Voir  Masquer  Télécharger

https://hal-unilim.archives-ouvertes.fr/hal-01497055
Contributeur : Claire Douady <>
Soumis le : mardi 28 mars 2017 - 11:34:07
Dernière modification le : lundi 22 janvier 2018 - 11:12:38
Document(s) archivé(s) le : jeudi 29 juin 2017 - 16:31:30

Fichier

art_10.1186_s12967-016-0765-4....
Fichiers éditeurs autorisés sur une archive ouverte

Licence


Copyright (Tous droits réservés)

Identifiants

Collections

Citation

Christophe Bounaix Morand Du Puch, Michelle Nouaille, Stéphanie Giraud, Anaïs Labrunie, Sandrine Luce, et al.. Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancer. Journal of Translational Medicine, BioMed Central, 2016, 14 (1), pp.10. 〈10.1186/s12967-016-0765-4〉. 〈hal-01497055〉

Partager

Métriques

Consultations de la notice

50

Téléchargements de fichiers

19